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Abstract FK506 binding protein 23 from mouse (mFKBP23) is
a peptidyl-prolyl cis-trans isomerase (PPIase) from the endo-
plasmic reticulum (ER), which consists of an N-terminal PPIase
domain and a C-terminal domain with Ca2+ binding sites. The
assay of adsorption from ER extract with glutathione S-trans-
ferase-mFKBP23 attached to glutathione-Sepharose 4B shows
that mFKBP23 binds to mouse immunoglobulin binding protein
(mBiP). The same assay with the recombinant proteins of the
N- and C-termini of mFKBP23 shows that the binding of the
C-terminus is Ca2+-dependent and the switch point is between
2 and 3 mM. By high concentration of Ca2+ this binding cannot
be detected. Furthermore, the Ca2+-regulated binding of
mFKBP23 and mBiP in ER can be detected by means of co-
immunoprecipitation.
/ 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Peptidyl-prolyl cis-trans isomerases (PPIases; EC 5.2.1.8)
are ubiquitous and abundant proteins and have been found
in bacteria, fungi, plants and animals. They are able to cata-
lyze the cis-trans isomerization of Xaa-Pro bonds in oligopep-
tides and proteins [1,2]. The PPIases belong to three structur-
ally unrelated families, namely the cyclophilins (CyPs), the
FK506 binding proteins (FKBPs) and the parvulin-like pro-
teins. They are characterized by their binding to speci¢c im-
munosuppressant drugs: cyclosporin A, FK506 and rapamy-
cin.
CyPs and FKBPs are able to accelerate slow refolding steps
in certain proteins in vitro and in vivo. Mitochondrial CyPs
from Neurospora crassa and yeast have been shown to be a
part of the protein folding machinery after the import involv-
ing molecular chaperones [3^5]. The immunophilin compo-
nents of the inactivated estrogen receptor, cyclophilin 40
and FKBP52, bind to Hsp90 with their tetratricopeptide re-
peat motif [6^8] involving molecular chaperones [9]. FKBP23
from mouse heart [10] and FKBP22 from N. crassa [11] are
PPIases from the endoplasmic reticulum (ER) and both con-
sist of an N-terminal PPIase domain and a C-terminal domain
of unknown function and FKBP23 is reported to possess
Ca2þ binding ability in the C-terminal domain. The alignment
of mouse (m) FKBP23 and mFKBP12 [12] showed that the
N-terminus of mFKBP23 (amino acids 20^137) belongs to a
PPIase domain.
Immunoglobulin binding protein (BiP), the Hsp70 in the
ER lumen, was the ¢rst member of the Hsp70 multigene fam-
ily that was initially identi¢ed on the basis of its speci¢c in-
teraction with the immunoglobulin (Ig) heavy chain [13^15].
BiP and all other Hsp70s are evolutionarily conserved. They
contain two functional domains, an amino-terminal 45 kDa
ATPase domain and a carboxy-terminal 25 kDa substrate
binding domain. The C-terminal domain consists of two parts,
eight L-sheets and ¢ve K-helices. The peptide binding site is
across the L-sheets [16^18]. Like all members of the Hsp70
family, BiP has a weak ATPase activity [19] to provide energy
for the protein translocation and the protein folding.
It was revealed in previous work that NcFKBP22, the
FKBP from the ER of N. crassa [11], binds to BiP in the
ER of N. crassa speci¢cally by using the yeast two-hybrid
system (Mi and Tropschug, unpublished). In view of the ho-
mology of mFKBP23 and NcFKBP22 in this work we study
the binding speci¢city of mFKBP23 to mBiP and the results
show that mFKBP23 binds speci¢cally to mBiP both in vitro
and in vivo. The binding of the C-terminus of mFKBP23 to
mBiP is Ca2þ-dependent and the switch point is between 2 and
3 mM of [Ca2þ]. By high concentration of [Ca2þ] this binding
cannot be detected. The N-terminus of mFKBP23 can bind
weakly to mBiP, but this binding is independent of the [Ca2þ].
These experiments show for the ¢rst time that a PPIase binds
to a molecular chaperone of the Hsp70 family.
2. Materials and methods
2.1. Constructions of plasmids expressing mFKBP23, mFKBP23N,
mFKBP23C and mBiP
For cloning of the full-length mFKBP23 protein, mouse mRNA
was ampli¢ed by reverse transcription-polymerase chain reaction
(RT-PCR) using an upstream primer (mFKBP23f) including an
EcoRI site (5P-ccggccgaattcagcactgaggaagtgaaaat-3P) and a down-
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stream primer (mFKBP23r) including an XhoI site (5P-ccggcctcgag
ggaaaacaggtataacca-3P). The ampli¢ed PCR product was digested
with EcoRI and XhoI restriction enzymes, and ligated into a bacterial
expression vector pGEX5X1.
For cloning of the full-length mBiP protein, mouse mRNA was
ampli¢ed by RT-PCR using an upstream primer (mBiPf) including
a BamHI site (5P-ccggccggatccaggaggacaagaaggagga-3P) and a down-
stream primer (mBiPr) including an XhoI site (5P-ggccggctcgagctaca
actcatctttttctgat-3P). The ampli¢ed PCR product was digested with
BamHI and XhoI restriction enzymes, and ligated into pGEX5X1.
For subcloning of the partial mFKBP23 proteins mFKBP23N and
mFKBP23C, the previously obtained pGEX5X1-mFKBP23 was used
as a template, and the primers used for PCR were: mFKBP23f as
an upstream primer and a downstream primer including an XhoI site
and a TAG stop codon, whose complementary sequence in primer
is labeled in bold (5P-ggccggctcgagctaggtcacagcataaagttcaat-3P), for
mFKBP23N, an upstream primer including an EcoRI site (5P-ggccg
gaattctatgctgtgaccaaaggacc-3P) and mFKBP23r as a downstream
primer for mFKBP23C, respectively. After digestion with restriction
enzymes, the PCR fragments were ligated into pGEX5X1.
The recombinant plasmid DNAs was transformed into competent
cells of Escherichia coli strain DH5K and the positive clones were
ampli¢ed. The puri¢ed recombinant plasmids DNAs were identi¢ed
with sequencing.
2.2. Puri¢cation of GST fusion protein and pure protein
The ampli¢ed bacteria containing the recombinant plasmid with the
target protein were induced with 0.1 mM isopropyl-L-D-thiogalactose.
The target proteins were expressed as glutathione S-transferase (GST)
fusion proteins and puri¢ed using glutathione-Sepharose 4B (Amer-
sham Pharmacia Biotech) as described [20]. The puri¢ed fusion pro-
teins could be restriction-digested on the beads with factor Xa (Amer-
sham Pharmacia Biotech) in a digestion bu¡er (50 mM Tris^HCl, pH
8.0, 1 mM CaCl2 and 100 mM NaCl) overnight at 25‡C. The puri¢ed
mFKBP23 was then con¢rmed by determining its PPIase activity as
described [21].
2.3. Preparation of ER extract from mouse liver
This was carried out as described by Borgeson and Bowman [22].
All steps of this procedure were performed at 4‡C and all bu¡ers and
the equipment were precooled at 4‡C. About 30 g mouse livers were
suspended with 10 ml bu¡er E (1 M sorbitol, 10 mM HEPES, pH 7.4
and 1 mM EDTA) and applied to homogenate. Then 1/10 volume of
NP-40 (3% solution) was added and shaken on ice for 5 min to break
the cells. The suspension was centrifuged for 20 min at 1000Ug and
the supernatant was collected. The pellet was suspended with 10 ml
bu¡er E and centrifuged for 20 min at 1000Ug once more. The two
supernatants were collected together and then centrifuged sequentially
at 12 000Ug and 40 000Ug for 1 h, respectively, to get the fractions
12P (pellet after centrifugation at 12 000Ug, nuclear and mitochon-
drial), 40P (pellet after centrifugation at 40 000Ug, microsome/endo-
plasmic reticulum) and 40S (supernatant after centrifugation at
40 000Ug, cytoplasm). Fraction 40P was washed cautiously with
5 ml bu¡er E and centrifuged for 30 min at 40 000Ug. The pellet
40P was suspended with 2 ml bu¡er E, sheared using a syringe and
centrifuged for 2 h at 100 000Ug. The supernatant is ER lumen ex-
tract and which was tested by Western blot to ensure there was no
contamination with cytosol.
2.4. In vitro binding assays
0.025 nmol mBiP in 400 Wl binding bu¡er (10 mM Tris^HCl, pH
7.5, 150 mM NaCl, 1 mM MgCl2 and 1 mM CaCl2) or 500 Wl ER
extract was incubated with glutathione-Sepharose 4B beads-attached
GST, GST-mFKBP23, GST-mFKBP23N or GST-mFKBP23C (0.2
nmol each) at room temperature for 30 min. The beads were washed
¢ve times with 1 ml binding bu¡er containing 0.1% Tween and once
with 1 ml binding bu¡er. The assay for reverse adsorption was con-
ducted with 0.025 nmol mFKBP23 in 400 Wl binding bu¡er and 0.2
nmol GST-mBiP attached to glutathione-Sepharose 4B beads, too.
For the Ca2þ-regulated binding assay 1 mM CaCl2 in the binding
bu¡er was replaced by 2 mM, 3 mM, 4 mM, 5 mM CaCl2 or 5 mM
EDTA. For the peptide competition assay, free or bead-attached
mBiP was preincubated with di¡erent doses of peptide V7 (FYQ-
LAKT) (50 WM, 100 WM or 200 WM per assay) for 2 h prior to the
procedure of binding with mFKBP23.
2.5. Immunoprecipitation (IP) for in vivo binding assays
Bound mFKBP23 or mBiP in 500 Wl ER extract was co-immuno-
precipitated by addition of anti-mFKBP23 or anti-mBiP antibodies
and incubated overnight. Then 40 Wl protein A-Sepharose (Pharmacia
Biotech) was added to the ER extract to absorb the antigen^antibody
complex. The beads were washed ¢ve times with 500 Wl washing bu¡er
(10 mM Tris^HCl, pH 7.5, 150 mM NaCl, 1% NP-40 and 10% glyc-
erol). For the Ca2þ-regulated binding assay, CaCl2 was added to the
ER extract to a ¢nal concentration of 1 mM, 2 mM, 3 mM or 4 mM
and incubated for 40 min, the extracts were then subjected to IP as
before.
2.6. Western blot
Proteins bound, described in Sections 2.4 and 2.5, were eluted by
the addition of sodium dodecyl sulfate (SDS) sample bu¡er. The
samples were analyzed by SDS^polyacrylamide gel electrophoresis
and transferred onto Hybond-C nitrocellulose membrane (Amersham
Life Science) at 0.8 mA/cm2 for 2 h. The membrane was blocked with
5% non-fat milk powder in TBS (50 mM Tris^HCl, pH 7.5 and 150
mM NaCl) for 1 h and incubated with rabbit anti-mFKBP23 or anti-
mBiP antiserum (1:500 diluted in TBS) overnight. The blots were
washed with TBS/Tween (0.1%) and then developed with alkaline
phosphatase-labeled goat anti-rabbit IgG (Sigma, 1:2000 diluted in
TBS). After washing with TBS/Tween the blots were developed by
the nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate sys-
tem in alkaline phosphatase bu¡er (100 mM Tris^HCl, pH 9.5, 100
mM NaCl and 5 mM MgCl2).
3. Results
3.1. Recombinant mFKBP23 binds speci¢cally to recombinant
mBiP
To investigate the binding of recombinant mFKBP23 and
mBiP to each other in vitro, we used puri¢ed mFKBP23 and
mBiP to carry out the binding assay. The result in Fig. 1A
shows that mBiP binds to GST-mFKBP23 in vitro, but does
not bind to GST alone. Fig. 1B demonstrates that mFKBP23
binds to GST-mBiP in vitro, but does not bind to GST alone.
Furthermore, there is no e¡ect of FK506 on this binding.
BiP is a member of the Hsp70 multigene family [23]. We
wanted to know if the mFKBP23 binds speci¢cally to mBiP
or if it binds also to Hsp70 or to other heat shock proteins.
Fig. 1. Evidence of binding of mFKBP23 to mBiP in vitro. A:
Western blot result of binding of GST-mFKBP23 to mBiP speci¢-
cally. Lane 1: 0.2 nmol GST alone; lane 2: 0.2 nmol GST incuba-
ted with 0.025 nmol mBiP as control; lane 3: 0.2 nmol GST-
mFKBP23 alone; lane 4: 0.2 nmol GST-mFKBP23 incubated with
0.025 nmol mBiP; lane 5: 0.005 nmol recombinant mBiP. B: West-
ern blot result of binding of GST-mBiP to mFKBP23 speci¢cally.
Lane 1: 0.2 nmol GST alone; lane 2: 0.2 nmol GST incubated with
0.025 nmol mFKBP23 as control; lane 3: 0.2 nmol GST-mBiP
alone; lane 4: 0.2 nmol GST-mBiP incubated with 0.025 nmol
mFKBP23; lane 5: 0.005 nmol recombinant mFKBP23.
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Binding tests with mFKBP23 to human Hsp60, Hsp70, Hsp90
or hamster BiP (StressGen) were performed. The result shows
that the binding of mFKBP23 to mBiP is speci¢c (data not
shown).
To test if the binding of mFKBP23 to mBiP also occurs in
the common peptide binding site of mBiP, the test peptide [24]
V7 (FYQLAKT, a peptide with high a⁄nity for all Hsp70s)
was used for competition binding assay and the competitor
peptide cannot in£uence the binding of mFKBP23 to mBiP at
di¡erent doses of peptide V7. It means that the mFKBP23
does not non-speci¢cally bind to the common peptide binding
site of mBiP.
3.2. The full-length and C-terminal domain of mFKBP23 can
bind to mBiP from the ER extract
To further investigate the binding of the recombinant
mFKBP23 to the natural mBiP in the ER, the GST-
mFKBP23 attached to glutathione-Sepharose 4B beads was
used for adsorption of mBiP from ER extract. As shown in
Fig. 2A, mBiP in the ER binds to GST-mFKBP23, but does
not bind to GST alone.
mFKBP23 consists of two domains. The N-terminus is a
PPIase domain with an FK506 binding site. The function of
the C-terminal domain is not clear so far apart from the fact
that it possesses Ca2þ binding ability on the two EF-hand
motifs. To examine which of the two domains is required
for the binding, GST fusion protein of the N-terminal domain
(amino acids 20^137) and the C-terminal domains of
mFKBP23, GST-mFKBP23N and GST-mFKBP23C, were
prepared for binding tests with ER extract. The result shows
that mFKBP23C can bind to mBiP strongly. For the
mFKBP23N a very weak binding to mBiP can be detected,
too (Fig. 2B).
3.3. The binding of mFKBP23C to mBiP is interrelated with
Ca2+ concentration
There are two EF-hand motifs on the C-terminal domain of
mFKBP23 protein [10]. Each EF hand possesses Ca2þ binding
ability according to Kretsinger’s rule [25]. Therefore, we asked
if the Ca2þ concentration could in£uence the binding of
mFKBP23 to mBiP. We investigated the binding capacity of
mFKBP23 to mBiP through di¡erent Ca2þ concentrations in
the binding bu¡er. As shown in Fig. 3A, the binding of
mFKBP23C and mBiP could be hardly detected when the
[Ca2þ] increased to 3 mM, whereas binding was observed
when [Ca2þ] was below 2 mM, suggesting that this binding
is regulated by the Ca2þ concentration in the solution, and the
switch point is between 2 and 3 mM. Compared with the
above observation, weak binding of mFKBP23N can be de-
tected in vitro, too. But this binding is unrelated to the con-
centration of Ca2þ (Fig. 3B).
3.4. mFKBP23 and mBiP exist in a bound complex form in
mouse ER and the binding is also in£uenced by Ca2+
concentration
To determine if the binding between mFKBP23 and mBiP
also occurs in vivo, we subjected isolated mouse ER extract to
co-immunoprecipitation. As shown in Fig. 4A, mBiP was co-
precipitated from the ER extract in the presence of anti-
mFKBP23. To investigate the Ca2þ in£uence on the binding
in vivo, we then adjusted the bu¡er of ER extract to di¡erent
Ca2þ concentrations and carried out IP as mentioned above.
Fig. 4B shows that mBiP can be detected when the [Ca2þ] was
lower than 2 mM, which accorded with the results in vitro.
We also wanted to ¢nd out whether the mFKBP23 can be
detected when anti-mBiP was used. As expected, the
mFKBP23 could be co-precipitated when the [Ca2þ] was low-
er than 2 mM (Fig. 4C). These results also provide support
for the investigation in vitro: the binding between mFKBP23
and mBiP exists in vivo, the binding is Ca2þ-regulated and the
switch point is between 2 and 3 mM [Ca2þ].
Fig. 2. Evidence of the binding of the C-terminal domain of
mFKBP23 to mBiP in the ER. A: Western blot result of adsorbed
mBiP from ER extract. Lane 1: 100 Wl ER extract only; lane 2: ad-
sorption of 500 Wl ER extract with 0.2 nmol GST-mFKBP23 bound
on glutathione-Sepharose 4B beads; lane 3: adsorption of 500 Wl
ER extract with 0.2 nmol GST only bound on glutathione-Sephar-
ose 4B beads. B: The C-terminal domain of mFKBP23 binds to
mBiP in the ER. Lane 1: 0.2 nmol GST-mFKBP23N incubated
with 500 Wl ER extract; lane 2: 0.2 nmol full-length mFKBP23 in-
cubated with 500 Wl ER extract; lane 3: 0.2 nmol GST-mFKBP23C
incubated with 500 Wl ER extract.
Fig. 3. The binding of mFKBP23 with mBiP is interrelated with
Ca2þ concentration. A: 0.025 nmol mBiP was adsorbed with 0.2
nmol GST-mFKBP23C in the binding bu¡er of di¡erent Ca2þ con-
centrations: 0, 1, 2, 3, 4 or 5 mM (lanes 1^6). The recombinant
mBiP was loaded to act as control (lane 7). The adsorbed mBiP
was detected with Western blot. B: The same assay using mBiP and
GST-mFKBP23N showed that the weak binding is unrelated to
[Ca2þ]. Lane 7 is the recombinant mBiP as control.
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4. Discussion
In this study we revealed binding of mFKBP23 to mBiP in
ER. This is evidence for the ¢rst time that a PPIase binds to a
molecular chaperone of the Hsp70 family. We also indicated
that the binding of the full-length (in vivo) and the C-terminus
of mFKBP23 with mBiP are interrelated with Ca2þ concen-
tration and the switch point of this binding is between 2 and 3
mM [Ca2þ]. The concentration of Ca2þ in the ER is between
2 and 3 mM [26]. Therefore, this [Ca2þ]-interrelated binding is
probably physiologically signi¢cant.
In the ER BiP is involved in polypeptide translocation,
protein folding or digestion of misfolded proteins and assem-
bly in the formation of multichain protein molecules, such as
antibody molecules [23,27]. Recent studies showed that BiP
maintains the permeability barrier of the ER membrane by
sealing the luminal end of the translocon pore before and
early in translocation [28]. The mFKBP23N can bind weakly
to mBiP. It could be a binding between PPIase and its sub-
strate site in BiP. We can presume that the complex of BiP
and FKBP23 represents one of BiP’s functions that will be
modulated by FKBP23’s PPIase activity. It will be a subject of
our further studies.
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Fig. 4. mFKBP23 and mBiP in the ER are bound and the binding
is Ca2þ-regulated. A: Western blot result of mBiP co-precipitated in
the presence of anti-mFKBP23 by IP. Lane 1: mFKBP23 antibody
(1 Wl) adsorbed from 500 Wl ER extract and the complex was tested
using anti-mBiP; lane 2: unrelated antibody (anti-cyclophilin 18)
was used as a control instead of anti-mFKBP23; lane 3: no anti-
body was used. B: The binding complex in ER was regulated by
[Ca2þ]. The [Ca2þ] in the ER extract was adjusted to 2 mM, 3 mM
or 4 mM (lanes 1^3) and was subjected to IP as before. C:
mFKBP23 was co-precipitated by adding 5 Wl mBiP antibody to the
ER extract. Furthermore, the [Ca2þ] was 1 mM, 2 mM, 3 mM or
4 mM (lanes 1^4).
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